Impact of Donor Hepatitis C Virus Infection Status on Death and Need for Liver Transplant in Hepatitis C Virus-Positive Kidney Transplant Recipients

被引:35
|
作者
Kucirka, Lauren M. [1 ]
Peters, Thomas G. [2 ]
Segev, Dorry L. [1 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[2] Univ Florida, Coll Med, Dept Surg, Jacksonville, FL USA
[3] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
关键词
Hepatitis C; kidney transplant; liver transplant; competing risks; RENAL-TRANSPLANTATION; SURVIVAL; DIALYSIS; RISK;
D O I
10.1053/j.ajkd.2012.03.015
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Only 29% of deceased donor kidney recipients with hepatitis C virus (HCV) receive HCV-positive (HCV+) kidneys. These kidneys are discarded 2.5 times more often than their HCV-negative (HCV-) counterparts, possibly due to the sense that an HCV+ kidney may adversely affect recipient liver function. The goals of this study were to characterize liver disease in HCV+ kidney recipients and compare rates of liver-related outcomes by kidney donor HCV status. Study Design: Observational cohort study. Setting & Participants: 6,250 patients with HCV who had a kidney transplant in 1995-2008 as captured in the United Network for Organ Sharing (UNOS) database. Liver-related outcomes were assessed by cross-linking with the liver waitlist and transplant data sets. Predictor: HCV status of transplanted kidney. Outcomes: Joining the liver waitlist, receiving a liver transplant, death. Measurements: Time to event. Results: Only 63 (1%) of HCV+ kidney recipients eventually joined the liver waitlist during the 13-year study period. Those who received HCV+ kidneys had a 2.6-fold higher hazard of joining the liver list (P < 0.001); however, the absolute difference in rate of listing between recipients of HCV- and HCV+ kidneys was <2%. This is consistent with findings of only 2% lower patient survival at 3 years in HCV+ patients receiving HCV+ versus HCV- kidneys. Limitations: We lacked data for HCV viral load and genotype of both HCV+ recipients and transplanted HCV+ kidneys. Conclusions: Because transplant with an HCV+ kidney may reduce waiting-time by more than a year for an HCV+ patient and there is a high risk of kidney waitlist mortality, a 2% increased rate of adverse liver outcomes and 2% increased rate of death at 3 years should not universally preclude the use of HCV+ kidneys when the intended recipient is also HCV+. Am J Kidney Dis. 60(1):112-120. (C) 2012 by the National Kidney Foundation, Inc.
引用
收藏
页码:112 / 120
页数:9
相关论文
共 50 条
  • [31] Transplant of Kidneys From Hepatitis C Virus-Positive Donors To Hepatitis C Virus-Negative Recipients: A Retrospective Study and Systematic Review
    Shadekejiang, Halinuer
    Zhu, Jiefu
    Wu, Xiongfei
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (12) : 1076 - 1084
  • [32] Apoptosis and hepatitis C virus infection in renal transplant recipients
    Delladetsima, Ioanna
    Psichogiou, Mina
    Alexandrou, Paraskevi
    Nikolopoulos, George
    Revenas, Kostantinos
    Hatzakis, Angelos
    Boletis, John
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (05) : 744 - 748
  • [33] Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data
    Gupta, Gaurav
    Kang, Le
    Yu, Jonathan W.
    Limkemann, Ashley J.
    Garcia, Victoria
    Bandyopadhyay, Dipankar
    Kumar, Dhiren
    Fattah, Hasan
    Levy, Marlon
    Cotterell, Adrian H.
    Sharma, Amit
    Bhati, Chandra
    Reichman, Trevor
    King, Anne L.
    Sterling, Richard
    CLINICAL TRANSPLANTATION, 2017, 31 (10)
  • [34] The challenge of recurrent hepatitis C virus in liver transplant recipients
    Marotta, Paul J.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 18 : 19C - 26C
  • [35] Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients
    Rostaing, L
    Izopet, J
    Arnaud, C
    Cisterne, JM
    Alric, L
    Rumeau, JL
    Duffaut, M
    Durand, D
    TRANSPLANTATION, 1999, 67 (04) : 556 - 560
  • [36] Prevalence of hepatitis C antibody positivity among spouses of liver transplant recipients with hepatitis C virus infection
    Gochu, JC
    Jensen, D
    Kaur, S
    Ganger, D
    Rosenblate, H
    GASTROENTEROLOGY, 1996, 110 (04) : A1198 - A1198
  • [37] Graft loss and racial mismatch in hepatitis C virus-positive liver transplant patients
    Kamal, Ahmad
    LIVER TRANSPLANTATION, 2012, 18 (05) : 505 - 506
  • [38] Calcineurin inhibition and disease recurrence in the hepatitis C virus-positive liver transplant recipient
    Pollard, S
    LIVER INTERNATIONAL, 2004, 24 (05) : 402 - 406
  • [39] Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection
    Delladetsima, JK
    Boletis, JN
    Makris, F
    Psichogiou, M
    Kostakis, A
    Hatzakis, A
    LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (04): : 294 - 300
  • [40] Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis
    Singh, N
    Gayowski, T
    Wagener, MM
    Marino, IR
    TRANSPLANTATION, 1996, 61 (03) : 402 - 406